Diagnostic Performance of Radiomics-Based Machine Learning in Differentiating Glioblastoma From Brain Metastasis: Systematic Review and Meta-Analysis
Journal of Medical Internet Research · 19.11.2026 · 28 · e104060
DOI: 10.2196/104060 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Medical Internet Research, online erschienen am 19.11.2026. Verfasst von Chen Hong und 7 weiteren Autor:innen. Die Arbeit nennt 75 Literaturangaben.
Abstract (Originalsprache)
Background
Glioblastoma (GBM) and brain metastasis (BM) are the most common malignant intracranial tumors in adults. Noninvasive differentiation between them remains challenging, as they frequently share similar imaging features. Although radiomics-based machine learning (ML) models show promise, systematic evidence of their performance remains limited.
Objective
We aimed to systematically estimate the diagnostic performance of radiomics-based ML models in differentiating GBM from BM and to explore multiclass classification involving primary central nervous system lymphoma (PCNSL), thereby assessing their potential for clinical use.
Methods
We systematically searched PubMed, Embase, Web of Science, and Cochrane Library databases from inception to January 22, 2026, for studies reporting the diagnostic performance of radiomics-based ML models for differentiating GBM from BM. Multiclass studies involving PCNSL were also retained. Methodological quality was appraised via the Radiomics Quality Score 2.0. Binary diagnostic accuracy was pooled using a bivariate random-effects model, stratified by internal and independent external validation. Multiclass sensitivities and specificities were pooled using separate joint generalized linear mixed models. Physician assessments were evaluated as an exploratory benchmark.
Results
A total of 39 studies (31 binary and 8 multiclass), involving 11,558 patients, were included. For binary classification, pooled sensitivity and specificity were 88.9% (95% CI 84.1%-92.4%) and 83.0% (95% CI 76.8%-87.9%) in internal validation, and 83.8% (95% CI 77.4%-88.7%) and 80.7% (95% CI 71.1%-87.7%) in external validation, respectively. In multiclass analyses, pooled sensitivity was 84.4% (95% CI 72.4%-91.8%) for GBM, 70.6% (95% CI 54.4%-82.8%) for BM, and 75.0% (95% CI 62.7%-84.3%) for PCNSL, with corresponding specificities of 82.5% (95% CI 70.1%-90.4%), 88.8% (95% CI 81.9%-93.3%), and 94.4% (95% CI 88.4%-97.4%), respectively.
Conclusions
Radiomics-based ML models could distinguish between GBM and BM in the included cohorts. However, due to methodological limitations and scarce evidence, their generalizability and clinical utility remain unclear. Further multicenter prospective studies should conduct independent external validation in consecutive patients. Trial Registration PROSPERO CRD420261295269; https://www.crd.york.ac.uk/PROSPERO/view/CRD420261295269
Zitieren
APA
Hong, C., Liu, G., Bie, Z., Guo, Y., Du, Y., Hu, Y., Li, S., & Liu, P. (2026). Diagnostic Performance of Radiomics-Based Machine Learning in Differentiating Glioblastoma From Brain Metastasis: Systematic Review and Meta-Analysis. Journal of Medical Internet Research, 28, e104060. https://doi.org/10.2196/104060
Vancouver
Hong C, Liu G, Bie Z, Guo Y, Du Y, Hu Y, et al. Diagnostic Performance of Radiomics-Based Machine Learning in Differentiating Glioblastoma From Brain Metastasis: Systematic Review and Meta-Analysis. Journal of Medical Internet Research. 2026;28:e104060. doi:10.2196/104060
BibTeX
@article{Hong2026,
author = {Hong, Chen and Liu, Gemingtian and Bie, Zhixu and Guo, Yuanhang and Du, Yi and Hu, Yanan and Li, Shiwei and Liu, Pinan},
title = {Diagnostic Performance of Radiomics-Based Machine Learning in Differentiating Glioblastoma From Brain Metastasis: Systematic Review and Meta-Analysis},
journal = {Journal of Medical Internet Research},
year = {2026},
volume = {28},
pages = {e104060},
doi = {10.2196/104060}
}
EUVIMED